RWM
CTSO icon

Ritholtz Wealth Management’s Cytosorbents Corp CTSO Stock Holding History

Ritholtz Wealth Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Hold
27,443
– – ﹤0.01% 1304
2026
Q1 		$15.5K Buy
+27,443
New +$18.7K ﹤0.01% 1190

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Ritholtz Wealth Management's CTSO Position: Q2 2026 in Review

Ritholtz Wealth Management held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 27,443 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Ritholtz Wealth Management first reported a position in CTSO in Q1 2026 and has held it in 2 quarters since. The position peaked at $15.5K in Q1 2026. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Ritholtz Wealth Management held 27,443 shares of Cytosorbents Corp worth $10.3K as of Q2 2026.
  • Ritholtz Wealth Management left its Cytosorbents Corp share count unchanged in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #1304 holding.
  • Ritholtz Wealth Management first reported a position in Cytosorbents Corp in Q1 2026 and has held it in 2 quarters since.
  • Ritholtz Wealth Management's Cytosorbents Corp position peaked at $15.5K in Q1 2026.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.